A xanthine oxidase inhibitor 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats

Carcinogenesis

Volumn 18, Issue 5, 1997, Pages 1113-1118

  Tanaka, Takuji ^a   Makita, Hiroki ^a   Kawamori, Toshihiko ^a   Kawabata, Kunihiro ^a   Mori, Hideki ^a   Murakami, Akira ^b   Satoh, Kumiko ^c   Hara, Akira ^c   Ohigashi, Hajime ^d   Koshimizu, Koichi ^b  

^a GIFU UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; ACETIC ACID; AZOXYMETHANE; CELL MARKER; ORNITHINE DECARBOXYLASE; POLYAMINE; UNCLASSIFIED DRUG; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOME NOR; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; INTESTINE CRYPT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THAILAND;

ANIMALS; ANTINEOPLASTIC AGENTS; AZOXYMETHANE; BODY WEIGHT; CELL DIVISION; COLON; COLONIC DISEASES; ENZYME INHIBITORS; INTESTINAL MUCOSA; LIVER; MALE; ORGAN SIZE; ORNITHINE DECARBOXYLASE; POLYAMINES; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; TERPENES; XANTHINE OXIDASE;

EID: 0031408861     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.5.1113     Document Type: Article

References (46)

1. Shike, M., Winawer, S.J., Greenwald, P.H., Bloch, A., Hill, M.J. and Swaroop, S.V. (1990) Primary prevention of colorectal cancer: the WHO Collaborating Centre for Prevention of Colorectal Cancer. Bull. World Health Organ., 68, 377-385.
2. Block, G., Patterson, B. and Subar, A. (1992) Fruit, vegetables, and cancer prevention: a review of epidemiological evidence. Nutr. Cancer, 18, 1-29.
3. Bird, R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
4. Pretlow, T.P., Barrow, B.J., Ashton, W.S., O'Riordan, M.A., Pretlow, T.G., Jurcisek, J.A. and Stellato, T.A. (1991) Aberrant crypts: Putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567.
5. McLellan, E.A., Medline, A. and Bird, R.P. (1991) Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res., 51, 5270-5274.
6. Pereira, M.A., Barnes, L.H., Rassman, V.L., Kelloff, G.V. and Steele, V.E. (1994) Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis (Lond.), 15, 1049-1054.
7. Tanaka, T. and Mori, H. (1996) Inhibition of colon carcinogenesis by non-nutritive constituents in foods. J. Toxicol. Pathol., 9, 139-149.
8. Mori, H., Tanaka, T., Sugie, S. and Yoshimi, N. (1995) Chemopreventive effects of plant derived phenolic, organosulfur and other compounds on carcinogenesis in digestive organs. Environ. Mutat. Res. Commun., 17, 127-133.
9. Tanaka, T. (1994) Cancer chemoprevention by natural products (Review). Oncol. Reports, 1, 1139-1155.
10. Tanaka, T., Kojima, T., Kawamori, T. and Mori, H. (1995) Chemoprevention of digestive organs carcinogenesis by natural product protocatechuic acid. Cancer, 75 (Suppl.), 1433-1439.
11. Cerutti, P.A. (1994) Oxy-radicals and cancer. Lancet, 344, 862-863.
12. Cerutti, P.A. (1991) Oxidant stress and carcinogenesis. Eur. J. Clin. Invest., 21, 1-5.
13. Parks, D.A. and Granger, D.N. (1986) Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol. Scand., 548 (Suppl.), 87-99.
14. McCord, J.M. and Fridovich, I. (1968) The reduction of cytochrome C by milk xanthine oxidase. J. Biol. Chem., 243, 5753-5760.
15. Kokoglu, E., Belce, A., Ozyurt, E. and Tepeler, Z. (1990) Xanthine oxidase levels in human brain tumours. Cancer Lett., 50, 179-181.
16. Reiners, J.J., Jr, Thai, G., Rupp, T. and Cantu, A.R. (1991) Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Part I. quantitation of superoxide dismutase, catalase, glutathione peroxidase and xanthine oxidase. Carcinogenesis, 12, 2337-2343.
17. Pence, B.C. and Reiners, J.J.J. (1987) Murine epidermal xanthine oxidase activity: correlation with degree of hyperplasia induced by tumour promoters. Cancer Res., 47, 6388-6392.
18. Wei, H., Bowen, R., Cai, Q., Barnes, S. and Wang, Y. (1995) Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med., 208, 124-130.
19. Klaunig, J.E. (1992) Chemopreventive effects of green tea components on hepatic carcinogenesis. Prev. Med., 21, 510-519.
20. Deschner, E.E., Ruperto, J., Wong, G. and Newmark, H.L. (1991) Quercetin and rutin as inhibitors of azoxymethane-induced colonie neoplasia. Carcinogenesis, 12, 1193-1196.
21. Yamane, T., Hagiwara, N., Tateishi, M., Akachi, S., Kim, M., Okuzumi, J., Kitao, Y., Inagake, M., Kuwata, K. and Takahashi, T. (1991) Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn. J. Cancer Res., 82, 1336-1339.
22. Tanaka, T., Makita, H., Kawabata, K., Mori, H., Kakumoto, M., Satoh, K., Hara, A., Sumida, T., Tanaka, T. and Ogawa, H. (1997) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by naturally occurring flavenoids diosmin and hesperidin. Carcinogenesis, 18, in press.
23. Mitsui, S., Kobayashi, S., Nagahori, H. and Ogiso, A. (1976) Constituents from seeds of Alpinia garanga wild, and their anti-ulcer activities. Chem. Pharm. Bull., 24, 2377-2382.
24. Noro, T., Sekiya, T., Katoh, M., Oda, Y., Miyase, T., Kuroyanagi, M., Ueno, A. and Fukushima, S. (1988) Inhibitors of xanthine oxidase from Alpinia galanga. Chem. Pharm. Bull., 36, 244-248.
25. Kondo, A., Ohigashi, H., Murakami, A., Suratwadee, J. and Koshimizu, K. (1993) 1′-Acetoxychavicol acetate as a potent inhibitor of tumour promoter-induced Epstein-Barr virus activation from Languas galanga, a traditional Thai condiment. Biosci. Biotech. Biochem., 57, 1344-1345.
26. Ohnishi, M., Tanaka, T., Makita, H., Kawamori, T., Mori, H., Satoh, K., Hara, A., Murakami, A., Ohigashi, H. and Koshimizu, K. (1996) Chemopreventive effect of a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn. J. Cancer Res., 87, 349-356.
27. Ronen, A. and Heddle, J.A. (1984) Site-specific induction of nuclear anomalies (apoptotic bodies and micronuclei) by carcinogens in mice. Cancer Res., 44, 1536-1540.
28. Wargovich, M.J., Goldberg, M.T., Newmark, H.L. and Bruce, W.R. (1983) Nuclear aberrations as a short-term test for genotoxicity to the colon: Evaluation of nineteen agents in mice. J. Natl Cancer Inst., 71, 133-137.
29. Tanaka, T., Kojima, T., Suzui, M. and Mori, H. (1993) Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumour development and biomarkers expression of colon tumourigenesis. Cancer Res., 53, 3908-3913.
30. Koide, T., Sakai, S., Takeda, A., Doi, T., Tei, K., Hara, A. and Sawada, H. (1986) Detection of polyamines by a new enzymatic differential assay. (4) Fundamental study on a new enzymatic differential assay of blood. Acta Urol. Jpn., 32, 913-917(in Japanese).
31. Pretlow, T.P., O'Riordan, M.A., Somich, G.A., Amini, S.B. and Pretlow, T.G. (1992) Aberrant crypts correlate with tumour incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13, 1509-1512.
32. Wargovich, M.J., Harris, C., Chen, C.-D., Palmer, C., Steele, V.E. and Kelloff, G.J. (1992) Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J. Cell. Biochem., 16G (Suppl.), 51-54.
33. Holt, P.R., Mokuolu, A.O., Distler, P., Liu, T. and Reddy, B.S. (1996) Regional distribution of carcinogen-induced colonic neoplasia in the rat. Nutr. Cancer, 25, 129-135.
34. Liu, T., Mokuolu, A.O., Rao, C.V., Reddy, B.S. and Holt, P.R. (1995) Regional chemoprevention of carcinogen-induced tumours in rat colon. Gastroenterology, 109, 1167-1172.
35. Wattenberg, L.W. (1990) Inhibition of carcinogenesis by minor anutrient constituents of the diet. Proc. Nutr. Soc., 49, 173-183.
36. Guyton, K.Z. and Kensler, T.W. (1993) Oxidative mechanisms in carcinogenesis. Br. Med. Bull., 49, 523-544.
37. Steele, V.E., Pereira, M.A., Sigman, C.C. and Kelloff, G.J. (1995) Cancer chemoprevention agent development strategies for genistein. J. Nutr., 125, 713S-716S.
38. Fiala, E.S. (1977) Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane Cancer, 40 (Suppl.), 2436-2445.
39. Fiala, E.S., Kulakis, C., Christiansen, G. and Weisburger, J.H. (1978) Inhibition of the metabolism of the colon carcinogen, azoxymethane, by pyrazole. Cancer Res., 38, 4515-4521.
40. Fiala, E.S., Caswell, N., Sohn, O.S., Felder, M.R., McCoy, G.D. and Weisburger, J.H. (1984) Non-alcohol dehydrogenase-mediated metabolism of methylazoxymethanol in the deer mouse, Peromyscus maniculatus. Cancer Res., 44, 2885-2891.
41. Oravec, C.T., Jones, C.A. and Huberman, E. (1986) Activation of the colon carcinogen 1,2-dimethylhydrazine in a rat colon cell-mediated mutagenesis assay. Cancer Res., 46, 5068-5071.
42. Zedeck, M.S., Frank, N. and Wiessler, M. (1979) Metabolism of the colon carcinogen methylazoxymethanol acetate. Front. Gastrointest. Res., 4, 32-37.
43. Fiala, E.S., Bobotas, G., Kulakis, C., Wattenberg, L.W. and Weisburger, J.H. (1977) Effects of disulfiram and related compounds on the metabolism in vivo of the colon carcinogen, 1,2-dimethylhydrazine. Biochem. Pharmacol., 26, 1763-1768.
44. Wattenberg, L.W., Lam, L.K.T., Fladmoe, A. and Borchert, P. (1977) Inhibitors of colon carcinogenesis. Cancer, 40, 2435-2445.
45. Wattenberg, L.W. (1985) Chemoprevention of cancer. Cancer Res., 45, 1-8.
46. Cohen, S.M. and Ellwein, L.B. (1990) Cell proliferation in carcinogenesis. Science, 249, 1007-1011.